Scott Estes

Scott Estes has been with Codiak BioSciences since they began operations in 2016. He has held several roles there focused on the development of the first scalable manufacturing process for engineered extracellular vesicles and the subsequent tech transfer to produce GMP material to support Codiak’s clinical programs. Prior to joining Codiak, Scott had roles at both Biogen and Genzyme leading cell line development and analytical support for early process development. Scott holds a PhD in Molecular and Cellular Biology from Roswell Park Cancer Institute and was a Post-Doctoral Fellow at the Massachusetts Institute of Technology.